Shahin Fazilat, MD
Plastic Surgery · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Fazilat’s office at (650) 964-2200 to ask if they take your plan before you enroll.
California Medical Board record
Licence A90907 · Current
Licensed to practise in California · since 2005 · expires 2028-05-31 · Howard University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Plastic Surgery - Plastic Surgery
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 38% of their 32 Part D prescriptions in 2015. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2023 | 15 | None | None | 0% | $118 |
| 2022 | 18 | None | None | 0% | $209 |
| 2021 | 14 | None | None | 0% | $344 |
| 2020 | 11 | None | None | 0% | $115 |
| 2019 | 15 | None | None | 0% | $259 |
| 2018 | 23 | 12 | None | 0% | $582 |
| 2017 | 18 | None | None | 0% | $499 |
| 2016 | 31 | 12 | None | None | $355 |
| 2015 | 32 | 14 | 38% (12) | 0% | $401 |
| 2014 | 19 | None | None | None | $439 |
| 2013 | 16 | 11 | None | 0% | $298 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2016: 1 drug
| Cephalexin | 14 | $99 | $7 |
2015: 1 drug
| Hydrocodone-Acetaminophen | 11 | $75 | $7 |
Money from drug and device companies
$1,938 in 2025
| 2025 | 4 | 43 | None | $1,938 |
| 2024 | 5 | 45 | $8,800 | $9,739 |
| 2023 | 5 | 41 | None | $1,996 |
| 2022 | 4 | 30 | None | $1,214 |
| 2021 | 6 | 27 | None | $855 |
| 2020 | 5 | 15 | None | $377 |
| 2019 | 9 | 36 | None | $3,859 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Motiva USA | Motiva Implant Matrix | $1,126 | 8 payments
|
| Abbvie | Botox | $697 | 30 payments
|
| Revance Therapeutics | Daxi | $65 | 3 payments
|
| Merz North America | None | $50 | 2 payments
|
See all 43 published payments
| Abbvie | Meals · 2025-11-18 | Natrelle Saline-Filled Breast Implants | $140 |
| Abbvie | Meals · 2025-11-18 | Botox | $13 |
| Abbvie | Meals · 2025-11-13 | Natrelle Saline-Filled Breast Implants | $7 |
| Abbvie | Meals · 2025-11-06 | Natrelle Saline-Filled Breast Implants | $11 |
| Motiva USA | Travel · 2025-10-26 | Motiva Implant Matrix | $452 |
| Motiva USA | Meals · 2025-10-26 | Motiva Implant Matrix | $325 |
| Motiva USA | Travel · 2025-10-26 | Motiva Implant Matrix | $25 |
| Motiva USA | Gift · 2025-10-26 | Motiva Implant Matrix | $87 |
| Abbvie | Meals · 2025-10-25 | Botox | $11 |
| Motiva USA | Meals · 2025-10-25 | Motiva Implant Matrix | $30 |
| Motiva USA | Meals · 2025-10-24 | Motiva Implant Matrix | $156 |
| Motiva USA | Meals · 2025-10-24 | Motiva Implant Matrix | $17 |
| Revance Therapeutics | Meals · 2025-10-22 | Daxi | $24 |
| Abbvie | Meals · 2025-10-21 | Botox | $21 |
| Abbvie | Meals · 2025-10-21 | Botox | $31 |
| Abbvie | Meals · 2025-10-07 | Botox | $21 |
| Abbvie | Meals · 2025-09-17 | None | $26 |
| Motiva USA | Meals · 2025-09-16 | Motiva Implant Matrix | $33 |
| Abbvie | Meals · 2025-09-03 | Botox | $12 |
| Abbvie | Meals · 2025-08-28 | Botox | $19 |
| Abbvie | Meals · 2025-07-24 | Natrelle Saline-Filled Breast Implants | $11 |
| Abbvie | Meals · 2025-07-19 | Botox | $14 |
| Abbvie | Meals · 2025-06-26 | Botox | $24 |
| Abbvie | Meals · 2025-06-04 | Natrelle Saline-Filled Breast Implants | $19 |
| Abbvie | Meals · 2025-05-29 | Botox | $8 |
| Revance Therapeutics | Meals · 2025-05-29 | None | $16 |
| Abbvie | Meals · 2025-05-23 | Botox | $12 |
| Abbvie | Meals · 2025-05-16 | Botox | $21 |
| Abbvie | Meals · 2025-05-02 | Natrelle Saline-Filled Breast Implants | $14 |
| Abbvie | Meals · 2025-04-14 | Botox | $25 |
| Abbvie | Meals · 2025-04-11 | None | $13 |
| Abbvie | Meals · 2025-04-03 | Natrelle Saline-Filled Breast Implants | $12 |
| Merz North America | Meals · 2025-04-03 | None | $33 |
| Abbvie | Meals · 2025-03-26 | Natrelle Saline-Filled Breast Implants | $8 |
| Abbvie | Meals · 2025-03-20 | Natrelle Saline-Filled Breast Implants | $9 |
| Revance Therapeutics | Meals · 2025-03-20 | Daxi | $25 |
| Abbvie | Meals · 2025-03-05 | Natrelle Saline-Filled Breast Implants | $8 |
| Abbvie | Meals · 2025-02-20 | Botox | $8 |
| Abbvie | Meals · 2025-02-13 | Natrelle Saline-Filled Breast Implants | $18 |
| Abbvie | Meals · 2025-02-08 | None | $15 |
| Merz North America | Meals · 2025-01-23 | None | $18 |
| Abbvie | Meals · 2025-01-10 | Botox | $122 |
| Abbvie | Meals · 2025-01-09 | Botox | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $9,739
| Solta Medical a division of Bausch Health US | None | $8,800 | 1 payment
|
| Abbvie | Natrelle Saline-Filled Breast Implants | $734 | 37 payments
|
| Merz North America | None | $96 | 4 payments
|
| Mentor Worldwide | Mentor Memorygel Resterilizable Gel Sizer | $81 | 2 payments
|
| Motiva USA | Motiva Implant Matrix | $29 | 1 payment
|
2023: $1,996
| Medical Device Business Services | None | $952 | 7 payments
|
| Abbvie | Natrelle Saline-Filled Breast Implants | $648 | 25 payments
|
| Mentor Worldwide | Mentor Memorygel Resterilizable Gel Sizer | $189 | 5 payments
|
| Galderma Laboratories L.P. | None | $139 | 1 payment
|
| Merz North America | None | $68 | 3 payments
|
2022: $1,214
| Allergan | Natrelle Saline-Filled Breast Implants | $592 | 18 payments
|
| Mentor Worldwide | Mentor Memorygel Resterilizable Gel Sizer | $377 | 7 payments
|
| Sientra | Sientra High Strength Cohesive Silicone Gel Breast Implant | $128 | 2 payments
|
| Merz North America | None | $117 | 3 payments
|
2021: $855
| Allergan | Natrelle Saline-Filled Breast Implants | $494 | 14 payments
|
| Mentor Worldwide | Mentor Memorygel Resterilizable Gel Sizer | $140 | 6 payments
|
| Sanara MedTech | Celleraterx | $118 | 1 payment
|
| Sientra | Sientra High Strength Cohesive Silicone Gel Breast Implant | $42 | 2 payments
|
| Merz North America | None | $35 | 2 payments
|
| Galderma Laboratories L.P. | None | $27 | 2 payments
|
2020: $377
| Sientra | Sientra High Strength Cohesive Silicone Gel Breast Implant | $133 | 3 payments
|
| Galderma Laboratories L.P. | None | $100 | 5 payments
|
| Allergan | Botox Cosmetic | $60 | 3 payments
|
| Apyx Medical | None | $49 | 2 payments
|
| Merz North America | Xeomin | $36 | 2 payments
|
2019: $3,859
| Allergan | Natrelle | $1,238 | 10 payments
|
| Medical Device Business Services | Artoura Breast Tissue Expander | $993 | 5 payments
|
| Musculoskeletal Transplant Foundation | None | $543 | 1 payment
|
| Apyx Medical | None | $485 | 5 payments
|
| Merz North America | Xeomin | $236 | 6 payments
|
| Solta Medical a division of Bausch Health US | None | $207 | 2 payments
|
| Sientra | Sientra High Strength Cohesive Silicone Gel Breast Implant | $116 | 1 payment
|
| Galderma Laboratories L.P. | None | $30 | 2 payments
|
| Mentor Worldwide | Memorygel Breast Implants | $12 | 1 payment
|
Professional record
- NPI
- 1649358599
- Licence
- CA A90907California A90907: Current · expires 2028-05-31
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 208200000X (208200000X)
- Mailing address
- 515 South Dr Ste 25, Mountain View, CA, 94040
- NPI first listed
- 2006-11-01
- NPI last updated
- 2023-06-16
- NPI record certified
- 2023-06-16
This is when the NPI record was last certified, not a medical board exam.